Difference between revisions of "Part:BBa K4656004"
(→Experimental results) |
|||
(19 intermediate revisions by 3 users not shown) | |||
Line 8: | Line 8: | ||
"Additionally, the best performing plasmid, pC4S-P4, contains a small part of the ler gene in the PLEE1 promoter region."[1] {The pC4S-P4: pDMB,PpchA-pchA-PLEE1(-98+218bp)-gfp;CmR} | "Additionally, the best performing plasmid, pC4S-P4, contains a small part of the ler gene in the PLEE1 promoter region."[1] {The pC4S-P4: pDMB,PpchA-pchA-PLEE1(-98+218bp)-gfp;CmR} | ||
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | The Plee promotor is under the control of PchA. We designed and compared Ppcha-pcha-Plee-egfp and Ppcha-pcha-egfp circuit. | ||
+ | |||
+ | ===Experimental results=== | ||
+ | |||
+ | <html><BR><BR><center><img style="display: block;-webkit-user-select: none;margin: auto;background-color: hsl(0,0%,90%);transition: background-color 300ms;" src="https://static.igem.wiki/teams/4656/wiki/build2.png"width="600" height="450"></center></html> | ||
+ | We designed two gene fragments as mentinoned: one directly attaching to EGFP downstream of the pchA promoter, and the other appending EGFP after the existing gene segment in enterohemorrhagic E. coli. We will compare the responsiveness and feedback levels of these two fragments to butyrate. | ||
+ | We cloned the synthesized A segment and B segment onto the pet-28a plasmid. Subsequently, we will individually transform these plasmids into Escherichia coli BL21. After plating and overnight incubation, we will extract an equal volume of bacterial culture and inoculate it into a 96-well plate containing LB medium and sodium butyrate. The plate will then be incubated in a microplate reader shaken at 37°C, simultaneously measuring fluorescence intensity and bacterial growth curve. | ||
+ | <p><html><BR><BR><center><img style="display: block;-webkit-user-select: none;margin: auto;background-color: hsl(0,0%,90%);transition: background-color 300ms;" src="https://static.igem.wiki/teams/4656/wiki/learn2.png"width="700" height="300"></center></html> | ||
+ | |||
+ | E. coli strains transfected with either A segment or B segment were cultivated in the presence of 10mM and 20mM sodium butyrate. The results revealed that the sensitivity of A segment to sodium butyrate and its ability to enhance the expression of downstream genes were superior to those of B segment. | ||
+ | In the end, we opted for the design of the A segment,which involves plee promotor. | ||
+ | |||
+ | ===Reference=== | ||
+ | [1]. Schwan W. R. (2011). Regulation of fim genes in uropathogenic Escherichia coli. World journal of clinical infectious diseases, 1(1), 17–25. https://doi.org/10.5495/wjcid.v1.i1.17. | ||
<!-- --> | <!-- --> | ||
Line 20: | Line 33: | ||
<partinfo>BBa_K4656004 parameters</partinfo> | <partinfo>BBa_K4656004 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
− | |||
− | |||
− |
Latest revision as of 12:36, 7 October 2023
PLEE1
PLEE1 is the promoter of the locus of enterocyte effacement which binds to pchA.
Since the specific binding site of pchA and PLEE1 is still unknown, at present, researchers have purchased Escherichia coli genome from atcc and amplified PLEE1 with different fragments by PCR as candidates, and constructed 6 different kinds of plasmids. +1 is the transcription start site TSS.
"Additionally, the best performing plasmid, pC4S-P4, contains a small part of the ler gene in the PLEE1 promoter region."[1] {The pC4S-P4: pDMB,PpchA-pchA-PLEE1(-98+218bp)-gfp;CmR}
Usage and Biology
The Plee promotor is under the control of PchA. We designed and compared Ppcha-pcha-Plee-egfp and Ppcha-pcha-egfp circuit.
Experimental results
Reference
[1]. Schwan W. R. (2011). Regulation of fim genes in uropathogenic Escherichia coli. World journal of clinical infectious diseases, 1(1), 17–25. https://doi.org/10.5495/wjcid.v1.i1.17.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]